RBC Capital Cuts DuPont de Nemours (DD) Price Target to $160
RBC Capital has maintained its Outperform rating on DuPont with a revised price target of $160, a 22.93% upside from the current price.
Reviewed by automated data checks against the source data. How we make and check alerts
RBC Capital cut its price target on DuPont de Nemours, Inc. ($DD) to $160 from $176 on October 15, 2026, and rates the stock "Outperform".
Since the rating, $DD is down 0.9% to date (from the $131.60 close on Oct 15, 2026).
DD
DuPont de Nemours, Inc.
Key Points
- On October 15, 2026, RBC Capital reiterated its Outperform rating on DuPont de Nemours, Inc. with a new price target of $160, down from $176.
- RBC Capital's $160 price target implies 22.93% upside from DuPont de Nemours, Inc.'s ($DD) current $130.16 share price.
- The stock is currently trading at $130.16, reflecting a decrease from its previous close of $129.01.
- DuPont has a market cap of around $17.5 billion and a P/E ratio of approximately 55.5.
Get $DD trade alerts by text
We text you when insiders, Congress or big funds trade $DD. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated DuPont de Nemours, Inc. alert may contain errors. Disclosures
RBC Capital has reiterated its Outperform rating on DuPont de Nemours, Inc. (NYSE: DD), adjusting the price target to $160 from the previous $176. This change was reported on October 15, 2026. The stock was trading at $130.16 on the same day, after closing at $129.01 previously.
RBC Capital vs. the S&P 500
Hypothetical returns from RBC Capital's disclosed trades, not real profit or advice. How we model this.
Other Institutional Activity in DuPont de Nemours, Inc.
Several institutional investors have been active in DuPont shares recently. Blackrock Inc. grew its holdings by 250,339 shares, resulting in a total of 10,637,868 shares valued at about $1.39 billion. State Street Corporation added 715,117 shares, bringing its total to 6,949,792 shares worth approximately $905.3 million. Vanguard Capital Management LLC increased its position by 70,918 shares, ending with 8,935,728 shares valued at around $1.16 billion.
DuPont de Nemours, Inc. Stock Down 1.1%
DuPont shares are currently trading at $130.16, which is near the middle of its 52-week range of $92.49 to $157.98. This positioning indicates that the stock could have room to grow, should it approach its previous highs. The shares are currently just below their 50-day moving average of $136.44.
$DD price target
DuPont de Nemours, Inc. daily closes and this analyst's $160 target. Not advice.
Recent Earnings
In its last earnings report, DuPont generated $6.99 billion in revenue, reflecting a growth rate of 4% year-over-year. The company reported earnings of $2.34 per share. DuPont is scheduled to announce its next earnings results on November 5, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
1 analysts raised price targets.
-
EPS & revenue
EPS beat estimates by 10.4%. Revenue missed estimates by 2.0%.
-
Profit surprise
EBITDA missed by 46 percent. Operating income missed by 52 percent.
-
Pre-earnings setup
Bar was high, analysts already very bullish.
-
Analyst signal
1 target raise.
-
Earnings quality
Gross margin up 3.2 points. Operating margin down 5.0 points. Positive free cash flow.
Earnings Call Summary
DuPont delivered a strong first quarter with organic sales growth of 2 percent and 20 percent adjusted earnings growth on a pro forma basis. Healthcare sales were especially strong at high single digit growth, while water was hampered by about $10 million in shipment delays from Middle East logistics disruptions. Management emphasized continued innovation, with plans to launch an AI platform for product development, and noted steady progress on their operational improvement program including Kaizen events. The company completed the Aramids divestiture and announced a $275 million accelerated share buyback, returning capital to shareholders while maintaining balance sheet strength.
Guidance DuPont raised full year sales guidance to about $7.2 billion and adjusted earnings to $2.35 to $2.40 per share. They expect about 4 percent organic growth for the year, including roughly 1 percent from pricing to cover higher raw material costs from the Middle East conflict. The company also projects strong margin expansion through the rest of the year.
Neutral report. Results and guidance were close to expectations, with limited evidence of a reset either way.
Insider Buying and Selling at DuPont de Nemours, Inc.
Recently, CEO Lori Koch sold 260 shares of DuPont on June 2, 2026, at an average price of $48.82, totaling approximately $12,741. This transaction was not part of a planned sale.
Analysts Set New Price Targets
On October 15, 2026, RBC Capital maintained its Outperform rating with a target of $160. Prior to this, Barclays initiated coverage with an Overweight rating and a target of $156 on October 13. Meanwhile, JP Morgan downgraded its rating to Neutral with a target of $145 on October 9, reflecting a shift in sentiment among analysts.
About DuPont de Nemours, Inc.
DuPont de Nemours, Inc. operates in the specialty chemicals industry, providing technology-based materials and solutions worldwide. The company focuses on two main segments: Healthcare & Water Technologies and Diversified Industrials. This diverse offering positions DuPont to address various market needs, especially as it adapts to changing industry demands.
Bottom Line
Investors should keep an eye on DuPont's upcoming earnings report on November 5, 2026, as it may provide further insights into the company's performance. Remember that the recent price target adjustments from analysts reflect their updated views and may influence trading in the short term. The information from RBC Capital's report is based on holdings as of the reporting period and may not represent current positions.
Related Filing Alerts
Source: RBC Capital's rating change on $DD (Oct 15, 2026). Written by software, not financial advice. How we make alerts